+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

IVD Market Brief Update

  • PDF Icon

    Report

  • 39 Pages
  • November 2021
  • Region: Global
  • Kalorama Information
  • ID: 5521658

What is the Size of the IVD Market in 2021?

 

What Major Trends are Affecting the Market in 2021?

Diagnostic test products have never been more important. This report is an update of the market for in vitro diagnostics products from analysts to reflect the latest information as of Q4 2021. As part of its coverage, this report contains market sizing for several major categories of IVD.


The demand for testing and movement of current and new technologies has continued to demonstrate gains in most areas of the IVD market. New products, changes in global health spending, regulatory changes in major markets, and disease trends are among the factors that produce a constantly evolving market picture. There are some growing segments in the market that have attracted industry attention. Among these are next-generation sequencing (NGS), cancer testing, and companion diagnostics technologies. Immunochemistry, point- of-care (POC) testing, and molecular diagnostics are also segments of great market interest, anticipated to be a big part of the future of IVD. The IVD market remains dynamic, demonstrating constant innovations.


The publisher has been diligent in outlining the IVD market and its rapidly changing landscape. COVID-19 has provided many positive aspects for the IVD diagnostic market but forecasting the market has become very difficult due to the uncertain progression of COVID-19. the publisher has been superior in accessing the market due to the extensive experience of its authors and commitment by the company to present the most accurate data available.

Table of Contents

CHAPTER 1: WORLDWIDE IVD MARKET - Q4 2021 UPDATE

IVD MARKET DEMAND AND GROWTH
Table 1-1: Global In Vitro Diagnostic Sales by Product Market, 2021 ($ million) (Clinical Chemistry; Immunoassays - non isotopic: Infectious disease, Other immunos, Blood bank screening, Drugs of Abuse, Diabetes HbA1c - lab; Hematology - Core Lab; Microbiology (ID/AST); Microbiology (molecular); Microbiology - Mass Spectrometry; Coagulation (PT/INR); Coagulation, molecular; Histology/cytology; HPV, molecular; Nucleic acid assays; Blood grouping/typing; Blood bank molecular - NAT Screens; Circulating tumor cells; POC, OTC diabetes; POC, OTC other; POC,
professional/hospital; Mass Spectrometry; Other IVD)
COVID-19 DIAGNOSTIC MARKETS
Table 1-2: COVID-19 Product Sales - Immunoassay (Antigen, Serology), Molecular, POC -, 2021 ($millions)
EFFECT OF COVID-19 ON MARKET SEGMENTS
Table 1-3: IVD Market excluding and with COVID-19, 2021
Figure 1-1: IVD Market Distribution by Segment
Table 1-4: Global In Vitro Diagnostic Market - YoY Growth 2020-2021
Figure 1-2: Global In Vitro Diagnostic Market - YoY Growth 2020-2021
Figure 1-3: IVD Segment Performance, Q1 2021 - Q4 2021
Figure 1-4: IVD Segment Performance, Total Market Value, 2021

CHAPTER TWO: PRODUCT TRENDS AND NEW DEVELOPMENTS

SELECTED NEW CORE IVD PRODUCT LAUNCHES AND DEVELOPMENTS
Clinical Chemistry
Hematology
Molecular
Companion Diagnostics
Microbiology
POC
Mass Spectrometry
COVID-19 Developments - September 2021 and Beyond
Figure 2-1: COVID-19 Test Market by Type, Q1-Q4 2021 Estimates - Rapid Testing Markets Remain
Strong
Antigen
Serology
Molecular

CHAPTER THREE: SELECTED IVD MARKET PARTICIPANT DEVELOPMENTS

SELECTED COMPETITIVE LEADER UPDATES
Figure 3-1: IVD Segment Growth by Leading Competitors, Change in Sales 2020-2021
Figure 3-2: Changes in Market Distribution for IVD Sales, 2019 & 2021 - Roche and Abbott Tie for #1
Spot
Q3 M&A ACTIVITY
Table 3-1: IVD Market M&A Activity, Q3 2021
ABBOTT LABORATORIES
Table 3-2: Abbott Corporate Summary
Company Update
AGILENT
Table 3-3: Agilent Summary
Company Update
BECTON DICKINSON AND CO
Table 3-4: BD Corporate Summary
Company Update
BIOMÉRIEUX SA
Table 3-5: bioMérieux Corporate Summary
Company Update
DANAHER
Table 3-6: Danaher Corporation Summary
Company Update
HOLOGIC, INC.
Table 3-7: Hologic Corporate Summary
Company Update
ILLUMINA
Table 3-8: Illumina Corporate Summary
Company Update
ORTHO CLINICAL DIAGNOSTICS
Table 3-9: Ortho Clinical Corporate Summary
Company Update
PERKIN ELMER
Table 3-10: Perkin Elmer Corporate Summary
Company Update
QUIDEL CORPORATION
Table 3-11: Quidel Corporate Summary
Company Update
ROCHE DIAGNOSTIC
Table 3-12: Roche Diagnostic Corporate Summary
Company Update
SIEMENS HEALTHINEERS
Table 3-13: Siemens Healthineers Corporate Summary
Company Update
THERMO FISHER SCIENTIFIC
Table 3-14: Thermo Fisher Scientific Corporate Summary
Company Update

CHAPTER FOUR: NEW OPPORTUNITIES

TELEHEALTH AND REMOTE PATIENT MONITORING UPDATE
Figure 4-1: Teladoc Quarterly Telehealth Services Performance 2020 and H1 2021 ($M)
MULTIPLEX AND SYNDROMIC TESTING
PERSONALIZED MEDICINE
POINT-OF-CARE